BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8535805)

  • 1. Impact of fine-needle aspiration cytology, ultrasonography and mammography on open biopsy rate in patients with benign breast disease.
    Green B; Dowley A; Turnbull LS; Smith PA; Leinster SJ; Winstanley JH
    Br J Surg; 1995 Nov; 82(11):1509-11. PubMed ID: 8535805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
    Garg S; Mohan H; Bal A; Attri AK; Kochhar S
    Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound guided fine needle aspiration cytology versus core biopsy in the preoperative assessment of non-palpable breast lesions.
    Ahmed ME; Ahmad I; Akhtar S
    J Ayub Med Coll Abbottabad; 2010; 22(2):138-42. PubMed ID: 21702288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final diagnoses following C3 (atypical, probably benign) breast cytology.
    Mottahedeh M; Rashid MH; Gateley CA
    Breast; 2003 Aug; 12(4):276-9. PubMed ID: 14659313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of fine-needle aspiration cytology, ultrasonography and mammography on open biopsy rate in patients with benign breast disease.
    Chadwick DR; Cuschieri RJ
    Br J Surg; 1996 Mar; 83(3):423. PubMed ID: 8665216
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical and suspicious categories in fine needle aspiration cytology of the breast: histological and mammographical correlation and clinical significance.
    Chaiwun B; Sukhamwang N; Lekawanvijit S; Sukapan K; Rangdaeng S; Muttarak M; Thorner PS
    Singapore Med J; 2005 Dec; 46(12):706-9. PubMed ID: 16308644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography-guided stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: prospective comparison with surgical biopsy results.
    Fajardo LL; Davis JR; Wiens JL; Trego DC
    AJR Am J Roentgenol; 1990 Nov; 155(5):977-81. PubMed ID: 2120967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-guided fine-needle aspiration cytology of nonpalpable breast lesions: Institut Curie's experience with 198 histologically correlated cases.
    Klijanienko J; Côté JF; Thibault F; Zafrani B; Meunier M; Clough K; Asselain B; Vielh P
    Cancer; 1998 Feb; 84(1):36-41. PubMed ID: 9500650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hamartoma of the breast: a clinicopathological review.
    Tse GM; Law BK; Ma TK; Chan AB; Pang LM; Chu WC; Cheung HS
    J Clin Pathol; 2002 Dec; 55(12):951-4. PubMed ID: 12461066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core biopsy vs fine needle aspiration cytology in a symptomatic breast clinic.
    Chuo CB; Corder AP
    Eur J Surg Oncol; 2003 May; 29(4):374-8. PubMed ID: 12711292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stereotactic and ultrasound guided fine-needle cytology in nonpalpable breast lesions].
    Vielh P; Klijanienko J
    Arch Anat Cytol Pathol; 1998; 46(4):237-40. PubMed ID: 9754384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic evaluation of fine needle aspiration cytology in the management of palpable breast lesions.
    Shah SH; Kayani N; Hasan SH; Soomro IN; Pervez S; Hussainy AS
    J Pak Med Assoc; 1998 Jan; 48(1):7-8. PubMed ID: 9610078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate cytodiagnosis and imaging in the clinical management of discrete benign breast lesions.
    Roche NA; Ray SA; Layer GT
    Ann R Coll Surg Engl; 1997 Jul; 79(4):268-71. PubMed ID: 9244070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of aspiration cytology in the diagnosis of breast disease.
    Smallwood J; Herbert A; Guyer P; Taylor I
    Br J Surg; 1985 Oct; 72(10):841-3. PubMed ID: 4041719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
    Carder PJ; Liston JC
    J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of non-palpable breast lesions: contribution of cytological punctures after stereotaxic localization].
    Meunier M; Le Gal M; Klijanienko J; Vielh P; Neuenschwander S; Durand JC; Asselain B
    J Radiol; 1995 May; 76(5):259-62. PubMed ID: 7783038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative high-risk lesions of the breast: contribution and limits of US-guided core biopsy.
    Zuiani C; Londero V; Bestagno A; Puglisi F; Di Loreto C; Bazzocchi M
    Radiol Med; 2005; 110(5-6):589-602. PubMed ID: 16437044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional targeting: a new three-dimensional ultrasound technique to evaluate needle position during breast biopsy.
    Weismann CF; Forstner R; Prokop E; Rettenbacher T
    Ultrasound Obstet Gynecol; 2000 Sep; 16(4):359-64. PubMed ID: 11169313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsuccessful preoperative biopsies, fine needle aspiration cytology or core needle biopsy, lead to increased costs in the diagnostic workup in breast cancer.
    Hukkinen K; Kivisaari L; Heikkilä PS; Von Smitten K; Leidenius M
    Acta Oncol; 2008; 47(6):1037-45. PubMed ID: 18607862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.